Quality Systems (Nasdaq: QSII ) is expected to report Q1 earnings on July 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Quality Systems's revenues will shrink -2.3% and EPS will wane -15.4%.
The average estimate for revenue is $115.6 million. On the bottom line, the average EPS estimate is $0.22.
Last quarter, Quality Systems tallied revenue of $111.3 million. GAAP reported sales were 2.1% higher than the prior-year quarter's $109.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.21. GAAP EPS were -$0.07 for Q4 versus $0.25 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 56.6%, 490 basis points worse than the prior-year quarter. Operating margin was 13.7%, 770 basis points worse than the prior-year quarter. Net margin was -3.7%, much worse than the prior-year quarter.
The full year's average estimate for revenue is $481.4 million. The average EPS estimate is $0.98.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 2,101 members out of 2,170 rating the stock outperform, and 69 members rating it underperform. Among 704 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 691 give Quality Systems a green thumbs-up, and 13 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Quality Systems is hold, with an average price target of $17.77.
Is Quality Systems the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Quality Systems to My Watchlist.